Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables
- PMID: 7779345
Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables
Abstract
All 1,101 clients residing in over 120 group homes of a residential services agency were surveyed on one date for presence of psychotropic medication. In all, 27% received one or more psychotropic drugs for behavioral or emotional disorders. Disorders and target behaviors listed for each drug group were examined and the relations between drug groups and diagnostic/demographic variables analyzed. In addition, logistic regression analyses were used to examine subject variable/drug relations further and the likelihood of receiving a specific class of medication given the presence of a subject variable. Certain physical and sensory handicaps were associated with less medication use. Generally speaking, the existence of DSM diagnoses (especially psychosis and mood disorder) and certain target behaviors were associated with greater medication use. In the main, medication use was consistent with known or presumptive indications for the respective drug groups, although unestablished applications were also observed.
Similar articles
-
[Treatment with psychotropic drugs in various facilities for mentally handicapped patients].Nervenarzt. 1993 Jul;64(7):451-5. Nervenarzt. 1993. PMID: 8103571 German.
-
Prevalence of psychoactive drug use among North Dakota group home residents.Am J Ment Retard. 1991 Sep;96(2):119-26. Am J Ment Retard. 1991. PMID: 1930945
-
Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.Am J Ment Retard. 1992 Mar;96(5):541-6. Am J Ment Retard. 1992. PMID: 1562312
-
Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):225-43, x-xi. Child Adolesc Psychiatr Clin N Am. 2000. PMID: 10674198 Review.
-
Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities.Am J Ment Retard. 1994 Sep;99(2):123-40. Am J Ment Retard. 1994. PMID: 7803030 Review.
Cited by
-
Clozapine for psychotic disorders in adults with intellectual disabilities.Cochrane Database Syst Rev. 2015 Sep 23;2015(9):CD010625. doi: 10.1002/14651858.CD010625.pub2. Cochrane Database Syst Rev. 2015. PMID: 26397173 Free PMC article.
-
Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism.J Autism Dev Disord. 2007 Jul;37(6):1080-5. doi: 10.1007/s10803-006-0248-1. J Autism Dev Disord. 2007. PMID: 17053989
-
Brief report: clonazepam behavioral side effects with an individual with mental retardation.J Autism Dev Disord. 2003 Jun;33(3):349-54. doi: 10.1023/a:1024466819989. J Autism Dev Disord. 2003. PMID: 12908837
-
Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.J Autism Dev Disord. 2003 Oct;33(5):527-34. doi: 10.1023/a:1025883612879. J Autism Dev Disord. 2003. PMID: 14594332